Sale!

SLC4A4 Gene Renal tubular acidosis proximal with ocular abnormalities Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The SLC4A4 gene plays a crucial role in maintaining the body’s acid-base balance by regulating bicarbonate transport in the kidneys. Mutations in this gene can lead to a condition known as renal tubular acidosis proximal with ocular abnormalities, a disorder characterized by the inability of the kidneys to properly acidify urine, leading to metabolic acidosis, and is often accompanied by eye abnormalities.

To diagnose this genetic condition, DNA Labs UAE offers a specialized genetic test that targets the SLC4A4 gene. This test is essential for individuals showing symptoms of the disorder or those with a family history of renal or ocular abnormalities. It involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed to identify any mutations in the SLC4A4 gene.

The cost of the SLC4A4 gene renal tubular acidosis proximal with ocular abnormalities genetic test at DNA Labs UAE is 4400 AED. This price includes the cost of sample collection, genetic analysis, and a comprehensive report detailing the findings. The results from this test can provide valuable information for diagnosis, allowing for appropriate management and treatment of the condition. It also offers the chance for genetic counseling to understand the implications for family members and future generations.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SLC4A4 Gene Renal Tubular Acidosis Proximal with Ocular Abnormalities Genetic Test

Test Name: SLC4A4 Gene Renal Tubular Acidosis Proximal with Ocular Abnormalities Genetic Test

Components: Sodium bicarbonate cotransporter 1 (NBCe1) protein

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Hepatology Nephrology Endocrinology Disorders

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for SLC4A4 Gene Renal Tubular Acidosis, Proximal, with Ocular Abnormalities NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC4A4 Gene Renal Tubular Acidosis, Proximal, with Ocular Abnormalities NGS Genetic DNA Test gene SLC4A4

Test Details

The SLC4A4 gene is responsible for producing a protein called sodium bicarbonate cotransporter 1 (NBCe1), which is involved in the transport of bicarbonate ions across cell membranes. Mutations in the SLC4A4 gene can lead to a condition called renal tubular acidosis, proximal, with ocular abnormalities.

Renal tubular acidosis (RTA) is a condition characterized by the inability of the kidneys to effectively remove acid from the body, leading to a buildup of acid in the blood. In proximal RTA, the dysfunction occurs in the proximal tubules of the kidneys, where bicarbonate reabsorption takes place. This leads to a decreased ability to reabsorb bicarbonate from the urine, resulting in a loss of bicarbonate and a buildup of acid in the blood.

In addition to the renal tubular acidosis, individuals with mutations in the SLC4A4 gene may also present with ocular abnormalities. These can include cataracts, glaucoma, and band keratopathy, which is the formation of a calcium deposit on the cornea.

NGS genetic testing, also known as next-generation sequencing, is a type of genetic test that can analyze multiple genes simultaneously to identify mutations or variations in the DNA sequence. It can be used to identify mutations in the SLC4A4 gene that may be causing renal tubular acidosis, proximal, with ocular abnormalities. This test can help in confirming the diagnosis, providing information about the specific mutation, and guiding treatment options.

Test Name SLC4A4 Gene Renal tubular acidosis proximal with ocular abnormalities Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Hepatology Nephrology Endocrinology Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SLC4A4 Gene Renal tubular acidosis, proximal, with ocular abnormalities NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC4A4 Gene Renal tubular acidosis, proximal, with ocular abnormalities NGS Genetic DNA Test gene SLC4A4
Test Details

The SLC4A4 gene is responsible for producing a protein called sodium bicarbonate cotransporter 1 (NBCe1), which is involved in the transport of bicarbonate ions across cell membranes. Mutations in the SLC4A4 gene can lead to a condition called renal tubular acidosis, proximal, with ocular abnormalities.

Renal tubular acidosis (RTA) is a condition characterized by the inability of the kidneys to effectively remove acid from the body, leading to a buildup of acid in the blood. In proximal RTA, the dysfunction occurs in the proximal tubules of the kidneys, where bicarbonate reabsorption takes place. This leads to a decreased ability to reabsorb bicarbonate from the urine, resulting in a loss of bicarbonate and a buildup of acid in the blood.

In addition to the renal tubular acidosis, individuals with mutations in the SLC4A4 gene may also present with ocular abnormalities. These can include cataracts, glaucoma, and band keratopathy, which is the formation of a calcium deposit on the cornea.

NGS genetic testing, also known as next-generation sequencing, is a type of genetic test that can analyze multiple genes simultaneously to identify mutations or variations in the DNA sequence. It can be used to identify mutations in the SLC4A4 gene that may be causing renal tubular acidosis, proximal, with ocular abnormalities. This test can help in confirming the diagnosis, providing information about the specific mutation, and guiding treatment options.